Clinical Trial Update: PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating PET imaging of cyclooxygenase-1 in participants with neurological manifestations of Long COVID / post-acute sequelae of SARS-C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Long COVID, Post Acute Sequelae of COVID-19 | Phase 1 | Status: RECRUITING